Nonpeptide substituted spirobenzoazepines as vasopressin...

Details Nonpeptide substituted spirobenzoazepines as vasopressin... Nonpeptide substituted spirobenzoazepines as vasopressin...

2008-04-29

2008-04-29

Anderson, Rebecca (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C540S586000, C540S543000

Reexamination Certificate

active

07365062

ABSTRACT:
The invention is directed to nonpeptide substituted benzodiazepines of Formula I,wherein A, X, n, R1, R2, R3, R4, R5, a and b are as described in the specification, which are useful as vasopressin receptor antagonists for treating conditions associated with vasopressin receptor activity such as those involving increased vascular resistance and cardiac insufficiency. Pharmaceutical compositions comprising a compound of Formula I and methods of treating conditions such as hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure, cerebral edema and ischemia, stroke, thrombosis, or water retention are also disclosed.

REFERENCES:
patent: 7238687 (2007-07-01), Chen et al.

Affiliated with

Also associated with

Rating

Nonpeptide substituted spirobenzoazepines as vasopressin... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nonpeptide substituted spirobenzoazepines as vasopressin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nonpeptide substituted spirobenzoazepines as vasopressin... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2768783